AAAAAA
Results:
1-20
|
Results: 20
Authors:
Moins, N
Papon, J
Seguin, H
Gardette, D
Moreau, MF
Labarre, P
Bayle, M
Michelot, J
Gramain, JC
Madelmont, JC
Veyre, A
Citation: N. Moins et al., Synthesis, characterization and comparative biodistribution study of a newseries of p-iodine-125 benzamides as potential melanoma imaging agents, NUCL MED BI, 28(7), 2001, pp. 799-808
Authors:
Samuels, SE
Knowles, AL
Tilignac, T
Debiton, E
Madelmont, JC
Attaix, D
Citation: Se. Samuels et al., Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice, AM J P-REG, 281(1), 2001, pp. R133-R139
Authors:
Ollier, M
Maurizis, JC
Nicolas, C
Bonafous, J
de Latour, M
Veyre, A
Madelmont, JC
Citation: M. Ollier et al., Joint scintigraphy in rabbits with Tc-99m-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging, J NUCL MED, 42(1), 2001, pp. 141-145
Authors:
Auzeloux, P
Papon, J
Pasqualini, R
Madelmont, JC
Citation: P. Auzeloux et al., Synthesis and biodistribution of a new oxo-technetium-99m bis(aminothiol) complex as a potential melanoma tracer, J MED CHEM, 44(7), 2001, pp. 1116-1121
Authors:
Marchenay, C
Cellarier, E
Levi, F
Rolhion, C
Kwiatkowski, F
Claustrat, B
Madelmont, JC
Chollet, P
Citation: C. Marchenay et al., Circadian variation in O-6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects, INT J CANC, 91(1), 2001, pp. 60-66
Authors:
Demidem, A
Morvan, D
Papon, J
De Latour, M
Madelmont, JC
Citation: A. Demidem et al., Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model, CANCER RES, 61(5), 2001, pp. 2294-2300
Authors:
Giraud, I
Rapp, M
Maurizis, JC
Madelmont, JC
Citation: I. Giraud et al., Application to a cartilage targeting strategy: Synthesis and in vivo biodistribution of C-14-labeled quaternary ammonium-glucosamine conjugates, BIOCONJ CHE, 11(2), 2000, pp. 212-218
Authors:
Bonicel, P
Michelot, J
Bacin, F
Papon, J
Kemeny, JL
Moins, M
Morvan, D
Madelmont, JC
Citation: P. Bonicel et al., Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma, MELANOMA RE, 10(5), 2000, pp. 445-450
Authors:
Nicolas, C
Borel, M
Maurizis, JC
Gallais, N
Rapp, M
Ollier, M
Verny, M
Madelmont, JC
Citation: C. Nicolas et al., Synthesis of N-quaternary ammonium [H-3] and [Tc-99m]polyazamacrocycles, potential radiotracers for cartilage imaging, J LABEL C R, 43(6), 2000, pp. 585-594
Authors:
Giraud, I
Rapp, M
Dupuy, JM
Maurizis, JC
Madelmont, JC
Citation: I. Giraud et al., Synthesis of carbon-14 labelled (3-{[(Z)-5-chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indol-1-yle]carbonylamino}propyl)trimethylammonium chloride, a potential cartilage-targeted antirheumatic drug, J LABEL C R, 43(3), 2000, pp. 297-308
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults
Authors:
Roche, H
Cure, H
Adenis, A
Fargeot, P
Terret, C
Lentz, MA
Madelmont, JC
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Roche et al., Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults, J NEURO-ONC, 49(2), 2000, pp. 141-145
Authors:
Maurizis, JC
Rapp, M
Nicolas, C
Ollier, M
Verny, M
Madelmont, JC
Citation: Jc. Maurizis et al., Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammoniumpropyl-cyclam, and N-[triethylammonium]-3-propyl-[15]ane-N5, potential cartilageimaging agents, DRUG META D, 28(4), 2000, pp. 418-422
Authors:
Auzeloux, P
Papon, J
Azim, EM
Borel, M
Pasqualini, R
Veyre, A
Madelmont, JC
Citation: P. Auzeloux et al., A potential melanoma tracer: Synthesis, radiolabeling, and biodistributionin mice of a new nitridotechnetium bis(aminothiol) derivative pharmacomodulated by a N-(diethylaminoethyl)benzamide, J MED CHEM, 43(2), 2000, pp. 190-198
Authors:
Samuels, SE
Knowles, AL
Tilignac, T
Debiton, E
Madelmont, JC
Attaix, D
Citation: Se. Samuels et al., Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice, CANCER RES, 60(17), 2000, pp. 4968-4974
Authors:
Auzeloux, P
Moreau, MF
Papon, J
Bayle, M
Borel, M
Pasqualini, R
Madelmont, JC
Citation: P. Auzeloux et al., Technetium-99m radiolabelling of an N-amino-alkyl-benzamide nitrido- and oxo-technetium bis(aminoethanethiol) derivative synthesis and biological results. Potential melanoma tracer agents., J LABEL C R, 42(6), 1999, pp. 567-579
Authors:
Auzeloux, P
Papon, J
Masnada, T
Borel, M
Moreau, MF
Veyre, A
Pasqualini, R
Madelmont, JC
Citation: P. Auzeloux et al., Synthesis and biodistribution of technetium-99m-labelled N-(diethylaminoethyl)benzamide via a bis(dithiocarbamate) nitridotechnetiuim(V) complex., J LABEL C R, 42(4), 1999, pp. 325-335
Authors:
Labarre, P
Papon, J
Moreau, MF
Moins, N
Veyre, A
Madelmont, JC
Citation: P. Labarre et al., Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting, EUR J NUCL, 26(5), 1999, pp. 494-498
Authors:
Irigaray, JL
Oudadesse, H
Brun, V
Labarre, P
Rapp, M
Madelmont, JC
Bonafous, J
Citation: Jl. Irigaray et al., Study of implanted biomaterial functionality by diphosphonate molecules labeled with radioactive Tc-99m, BIOL TR EL, 71-2, 1999, pp. 629-633
Authors:
Nicolas, C
Verny, M
Giraud, I
Ollier, M
Rapp, M
Maurizis, JC
Madelmont, JC
Citation: C. Nicolas et al., New quaternary ammonium oxicam derivatives targeted toward cartilage: Synthesis, pharmacokinetic studies, and antiinflammatory potency, J MED CHEM, 42(25), 1999, pp. 5235-5240
G(2) accumulation and melanin overproduction in malignant melanocytes treated with a new nitrosourea
Authors:
Buchdahl, C
Papon, J
Communal, Y
Bourges, M
Madelmont, JC
Citation: C. Buchdahl et al., G(2) accumulation and melanin overproduction in malignant melanocytes treated with a new nitrosourea, MELANOMA RE, 8(6), 1998, pp. 517-527
Risultati:
1-20
|